Literature DB >> 7595064

Nitric oxide synthase in circulating vs. extravasated polymorphonuclear leukocytes.

A M Miles1, M W Owens, S Milligan, G G Johnson, J Z Fields, T S Ing, V Kottapalli, A Keshavarzian, M B Grisham.   

Abstract

It is becoming increasingly apparent that certain forms of acute and chronic inflammation are associated with enhanced production of nitric oxide (NO). Although substantial information has been obtained describing the regulation of NO synthase (NOS) in macrophages, little information is available regarding the biochemistry and molecular biology of NOS in circulating vs. extravasated polymorphonuclear leukocytes (PMNs). The objective of this study was to characterize the molecular and biochemical properties of the inducible NO synthase (iNOS) in circulating vs. extravasated rat and human PMNs. Circulating rat and human PMNs were purified from peripheral blood and extravasated PMNs were elicited in rats by intraperitoneal injection of 1% oyster glycogen or in humans by peritoneal dialysis of patients with peritonitis. Inducible NOS mRNA from circulating and elicited PMNs was quantified using slot blot hybridization analysis with a cDNA probe specific for iNOS. iNOS protein was identified using Western immunoblot analysis, and NOS activity was quantified by measuring the NG-monomethyl-L-arginine (L-NMMA)-inhibitable conversion of 14C-labeled L-arginine to L-[14C]citrulline. In a separate series of experiments, circulating or extravasated PMNs were cultured for 4 h and the accumulation of L-NMMA-inhibitable nitrite (NO2-) in the supernatant was determined and used as a measure of NO production in vitro. We found that circulating PMNs (rat or human) contained no iNOS mRNA, protein, or enzymatic activity. Furthermore, circulating rat or human PMNs (2 x 10(6) cells/well) were unable to generate significant amounts of NO2- when cultured for 4 h in vitro. In contrast, iNOS mRNA levels in 4- and 6-h elicited rat PMNs increased 21- and 42-fold, respectively, when compared with circulating cells. Western blot analysis revealed the presence of iNOS protein in the elicited rat PMNs and iNOS enzymatic activity increased from normally undetectable levels in circulating rat PMNs to 81 and 285 pmol/min/mg for the 4- and 6-h elicited rat PMNs, respectively. Approximately 20-30% of the total iNOS activity was Ca(2+)-dependent. Nitrite formation by elicited rat PMNs in the absence of any exogenous stimuli increased from normally undetectable amounts for circulating PMNs to approximately 8 and 11 microM/10(6) cells for the 4- and 6-h elicited PMNs, respectively. Highly enriched preparations of extravasated human PMNs contained neither message, protein nor iNOS enzymatic activity. Taken together our data demonstrate that inflammation-induced extravasation of rat PMNs upregulates the transcription and translation of iNOS in a time-dependent fashion and that 20-30% of the total inducible NOS is Ca(2+)-dependent. In contrast, neither circulating nor extravasated human PMNs contained iNOS message, protein, or enzymatic activity. These data suggest that the human PMN iNOS gene is under very different regulation than is the rat gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7595064     DOI: 10.1002/jlb.58.5.616

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  12 in total

1.  Bacterial infection induces nitric oxide synthase in human neutrophils.

Authors:  M A Wheeler; S D Smith; G García-Cardeña; C F Nathan; R M Weiss; W C Sessa
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

2.  Induced nitric oxide (NO) synthesis in heterologous nephrotoxic nephritis; effects of selective inhibition in neutrophil-dependent glomerulonephritis.

Authors:  S N Waddington; K Mosley; V Cattell
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

3.  Effect of adhesion on inducible nitric oxide synthase (iNOS) production in purified human neutrophils.

Authors:  J L Webb; J M Polak; T J Evans
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

4.  Differential inducible nitric oxide synthase activity in circulating neutrophils vs. mononuclears of septic shock patients.

Authors:  Moshe Hersch; Jeremy A Scott; Gabriel Izbicki; David McCormack; Gedeminas Cepinkas; Marlies Ostermann; William J Sibbald
Journal:  Intensive Care Med       Date:  2005-06-15       Impact factor: 17.440

5.  Neutrophils, nitric oxide synthase, and mutations in the mutatect murine tumor model.

Authors:  J K Sandhu; H F Privora; G Wenckebach; H C Birnboim
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

6.  Molecular and metabolic evidence for the restricted expression of inducible nitric oxide synthase in healing wounds.

Authors:  J S Reichner; A J Meszaros; C A Louis; W L Henry; B Mastrofrancesco; B A Martin; J E Albina
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

7.  Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice.

Authors:  D M McCafferty; M Miampamba; E Sihota; K A Sharkey; P Kubes
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

8.  Comparison of inducible nitric oxide synthase expression in the brains of Listeria monocytogenes-infected cattle, sheep, and goats and in macrophages stimulated in vitro.

Authors:  T W Jungi; H Pfister; H Sager; R Fatzer; M Vandevelde; A Zurbriggen
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

9.  Involvement of endogenous nitric oxide in myeloperoxidase mediated benzo(a)pyrene induced polymorphonuclear leukocytes injury.

Authors:  Abhai Kumar; Suman Patel; Yogendra Kumar Gupta; Mahendra Pratap Singh
Journal:  Mol Cell Biochem       Date:  2006-03-16       Impact factor: 3.396

10.  Tumor necrosis factor alpha stimulates killing of Mycobacterium tuberculosis by human neutrophils.

Authors:  Kevin O Kisich; Michael Higgins; Gill Diamond; Leonid Heifets
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.